Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q4 2017 Earnings

7NovConfirmed

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-5.55

-4.7

-3.85

-3

Details

Expected EPS

-4.15

Actual EPS

-3

Surprise EPS

1.15

Surprise Percent

+27.71%

Description

Celldex Therapeutics (CLDX) has reported earnings of -3 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.